Scientists think that cannabidiol stimulates the endocannabinoid system by increasing the levels of anandamide in the body, so far studies suggest that CBDa doesn’t interact with the endocannabinoid system, but it may affect, instead, other non-endocannabinoid receptors and enzymes.
When we say cannabidiol and cannabidiolic acid are close relatives, it is because the second actually is the precursor to the first. So how does it become cannabidiol? That transition occurs when CBDa is decarboxylated either through combustion, heating up through cooking, or via vaporization.
The removal of the carboxyl group is what gives us the more famous cannabinoids. However, retaining that carboxyl group does not seem to negatively affect the compound’s health benefits.
No psychoactive properties
For consumers that want to focus on cannabidiol and its benefits, source from the best cannabinoids manufacturers. If your business provides cannabinoids, don’t forget the lesser-known Cannabidiolic Acid. It is just as healthy as CBD, help your customers include it in their diet.
Though research on this specific cannabinoid has been somewhat limited–especially compared to research done on THC and CBD–there is evidence that cannabidiolic acid has anti-inflammatory properties, and it may even help combat cancer.
While the current research labels CBDa as one of the least effective cannabinoids for treating cancer, that is likely only due to the dearth of research that’s been done. It’s clear that it is non-psychoactive–like CBD–but more research into its medicinal benefits will likely elucidate its potential as an equally powerful medicine.